VIVO Cannabis Inc.

Recent News

  • VIVO Cannabis Announces Agreement to Amend Outstanding Debentures

    Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company") has entered into an agreement dated September 15, 2022 with the majority beneficial owner of its outstanding unsecured convertible debentures dated February 28, 2018 in the aggregate principal amount of $5,546,808 (collectively, the "Debentures") to amend the terms of the Debentures (the "Amendments")."We are pleased to have reached an agreement which mitigates our financial risk profile while allowing us to fulfill...

    2022-09-19 8:00 AM EDT
  • VIVO Cannabis Announces Second Quarter 2022 Results

    Net revenue for Q2 2022 was $5.2 millionCompany announced that Canna Farms received a Research Licence from Health Canada in June, 2022 Canadian Launch of Fireside™ Pink Kush and Girl Scout Cookies Full-Spectrum 510 VapesAustralian sales delayed due to new regulatory requirements Company announces cost savings workforce reductions focused on its Hope, BC Canna Farms facilityCompany continues to grow sales in Germany completing the 5th export of dry flower from its EU-GMP certified facility in Napanee, ONToronto, Ontario--(News

    2022-08-15 6:26 PM EDT
  • VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada

    Toronto, Ontario--(Newsfile Corp. - July 22, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced that Canna Farms has received a Research Licence from Health Canada allowing it to possess cannabis for the purpose of research. The Research Licence allows Canna Farms to evaluate...

    2022-07-22 7:30 AM EDT
  • VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

    Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting"). As announced this morning, at the Meeting, shareholders approved fixing the number of directors at five, and the election of Ray Laflamme, Glen Huber, Shai Altman, Eric Shipman and Holly Workman as directors...

    2022-07-02 12:16 AM EDT
  • VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients

    Toronto, Ontario--(Newsfile Corp. - June 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced results from its first study investigating how medical cannabis impacts anxiety and depression outcomes. The publication, entitled "Medical cannabis use in Canada and its impact on anxiety and depression:...

    2022-06-03 7:30 AM EDT
  • VIVO Cannabis Announces First Quarter 2022 Results

    Net revenue for Q1 2022 was $6.9 millionVIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenueCanadian Launch of Canna Farms Single-strain Oils, Infused Pre-rolls, Top Cola Signature Series and Fireside CBD Canna Bliss 510 Vape Cartridge and 10 pack CBD ChocolatesHarvest Medicine study on medical cannabis outcomes in anxiety & depression accepted for publication in Psychiatric ResearchToronto, Ontario--(Newsfile Corp. - May 16, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the...

    2022-05-16 10:00 PM EDT
  • VIVO Cannabis Announces Fourth Quarter 2021 Results

    Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million.In February 2021, closed a $7.2 million equity raise to help fund VIVO's growth In July 2021, the Company elected a new Board of Directors, announced the appointment of Ray Laflamme as CEO and Chairman of the Board and later welcomed the Former President of McCain Foods Canada and CEO of Zenabis Global, and Former CFO of Cronos Group, to the Board of Directors. In...

    2022-03-31 7:57 AM EDT
  • VIVO Cannabis(TM) Adds Assuage Suppositories to Online Medical Marketplace

    Toronto, Ontario--(Newsfile Corp. - February 11, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc., today announced a partnership with Cicatrix Labs Ltd. ("Cicatrix Labs") to offer Assuage™ vaginal and rectal suppositories on VIVO's Canna Farms e-commerce marketplace."In keeping with our laser focused medical strategy,...

    2022-02-11 7:00 AM EST